September 2026
1. LIU X, Fang E, Xu H, Liu X, et al
   Immunogenicity of a Vero cell-adapted Japanese encephalitis attenuated virus strain SA14-14-2 VC(6).
   Arch Virol. 2026;171:276.
   

   >> Share

   
   August 2026
2. GROSS S, Dalphin L, Dor F, Ramanah R, et al
   Frequent detection of high-risk HPV types other than HPV 16/18 in a cohort of French women who claimed to have been vaccinated.
   Arch Virol. 2026;171:262.
   

   >> Share

   
   
3. RIAZ MR, Kamran Ullah SM, Rashid M, Ullah K, et al
   Adaptation of wild-type rabies virus on vaccine producing cell line and its quantification by peroxidase-based immunostaining.
   Arch Virol. 2026;171:254.
   

   >> Share

   
   July 2026
4. ENKHMANDAKH Y, Odonchimeg M, Munkhtsetseg A, Batmagnai E, et al
   Effective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206.
   Arch Virol. 2026;171:234.
   

   >> Share

   
   May 2026
5. IQBAL H, Ahmad F, Ahmad S, Ahmad I, et al
   Phylogenetic and genome-wide analysis of codon usage reveals geographic and host-specific adaptation in Vaccinia virus.
   Arch Virol. 2026;171:178.
   

   >> Share

   
   March 2026
6. TRAN TT, Andronicos NM, Ketheesan N, Walkden-Brown SW, et al
   Immune responses in chicken mucosal lymphoid tissues following oral and eye drop vaccination and revaccination with live modified vaccine of infectious laryngotracheitis virus (ILTV).
   Arch Virol. 2026;171:132.
   

   >> Share

   
   
7. AFZAL H, Umar M, Hoa NT, Ke GM, et al
   Enhancing the immunogenicity of a recombinant PEDV subunit vaccine: the role of lipoprotein signal peptide.
   Arch Virol. 2026;171:131.
   

   >> Share

   
   February 2026
8. AHMAD MM, Gulzar MW, Azeem MW, Mubashar MM, et al
   Molecular Detection and Phylogenetic Characterization of Avian Infectious Bronchitis Virus (IBV) in Vaccinated Commercial Chicken Flocks Experiencing Outbreaks in Faisalabad, Pakistan.
   Arch Virol. 2026;171:73.
   

   >> Share

   
   
9. ZHANG X, Liu Y, Yin B, Li C, et al
   Construction of recombinant OPIV3 virus vectoring bivalent Mycoplasma ovipneumoniae adhesins.
   Arch Virol. 2026;171:74.
   

   >> Share

   
   January 2026
10. ZHANG J, Sun X, Koro C, Fang Y, et al
    Prevalence of group A rotavirus G and P genotypes in children with acute gastroenteritis in China from 2020 to 2021.
    Arch Virol. 2026;171:47.
    

    >> Share

    
    
11. DE OLIVEIRA BARBOSA A, Gava D, Bastos APA, de Lima M, et al
    Immunogenicity of an inactivated vaccine against senecavirus a and duration of the immune response in pigs.
    Arch Virol. 2026;171:33.
    

    >> Share

    
    December 2025
12. CHAI Y, Hu Z
    Adaptive immune response of poultry to Newcastle disease vaccines.
    Arch Virol. 2025;171:14.
    

    >> Share

    
    
13. JAMOUR P, Babaeimarzangou SS, Daneshvar Hosseini N, Gholizadeh Gigloo M, et al
    Immunogenetic insights into matching bivalent inactivated Payavax G79(R) for sustainable poultry vaccination against NDV-GVII and H9N2.
    Arch Virol. 2025;171:13.
    

    >> Share

    
    November 2025
14. LATEEF MO, Aransi AT, Nathaniel D
    Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development.
    Arch Virol. 2025;171:7.
    

    >> Share

    
    
15. HUSSEIN NA, Azouz RAM, El-Shenawy R, Helmy NM, et al
    A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice.
    Arch Virol. 2025;170:244.
    

    >> Share

    
    October 2025
16. RYU NG, Yang YJ, Kim KI
    Application of a multi-epitope DNA vaccine against viral hemorrhagic septicemia virus type ?a.
    Arch Virol. 2025;170:222.
    

    >> Share

    
    September 2025
17. CUI X, Wang S, Han Q, Jin N, et al
    Molecular characterization of infectious laryngotracheitis virus in China and host transcriptomic responses to immunization with a live attenuated vaccine.
    Arch Virol. 2025;170:216.
    

    >> Share

    
    August 2025
18. ZADEH MEHRIZI T, Eshrati B, Ebrahimi Shahmabadi H
    Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review.
    Arch Virol. 2025;170:193.
    

    >> Share

    
    July 2025
19. NEMOTO M, Kawanishi N, Kambayashi Y, Bannai H, et al
    Growth properties of recombinant equine influenza viruses with different backbones generated by reverse genetics in embryonated chicken eggs.
    Arch Virol. 2025;170:181.
    

    >> Share

    
    June 2025
20. MULONDO G, Buyse MLR, Labuschagne K, Jarvis D, et al
    Production and immunogenicity of a plant-produced beak and feather disease virus vaccine in Japanese quails.
    Arch Virol. 2025;170:163.
    

    >> Share

    
    
21. WANG L, Yang X, Zhang B, Hao S, et al
    Construction and evaluation of a recombinant duck enteritis virus expressing the envelope protein of duck Tembusu virus in ducks.
    Arch Virol. 2025;170:153.
    

    >> Share

    
    May 2025
22. CHEN T, Xu W, Duan P, Jiang S, et al
    MF59-like adjuvant containing yeast-derived squalene enhances the humoral immune response to cell-derived influenza vaccine.
    Arch Virol. 2025;170:134.
    

    >> Share

    
    March 2025
23. YE QY, Jiang ZT, Jiang Y, Cai JW, et al
    Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant.
    Arch Virol. 2025;170:88.
    

    >> Share

    
    February 2025
24. KOTHARI D, Patel N, Bishoyi AK
    Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies.
    Arch Virol. 2025;170:48.
    

    >> Share

    
    January 2025
25. ASHRAF MA, Raza MA, Imran A, Amjad MN, et al
    Next-generation vaccines for influenza B virus: advancements and challenges.
    Arch Virol. 2025;170:25.
    

    >> Share

    
    December 2024
26. SORDO-PUGA Y, Santana-Rodriguez E, Perez-Perez D, Mendez-Orta MK, et al
    Porvac((R)) subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypes.
    Arch Virol. 2024;170:22.
    

    >> Share

    
    
27. OLORUNTIMEHIN ES, Volodina SI, Patraman IV, Nadtochey GA, et al
    Molecular and ultrastructural characteristics of virulent and attenuated vaccine strains of goose parvovirus LIV-22.
    Arch Virol. 2024;170:4.
    

    >> Share

    
    July 2024
28. LIU C, Li S, Qiao M, Zeng C, et al
    GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection.
    Arch Virol. 2024;169:167.
    

    >> Share

    
    
29. LUO J, Zhang M, Ye Q, Gao F, et al
    A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice.
    Arch Virol. 2024;169:163.
    

    >> Share

    
    April 2024
30. ALVAREZ-QUINTO R, Grinstead S, Kinard G, Martin R, et al
    Complete genome sequence of vaccinium-associated virus C, a new member of the family Totiviridae from Vaccinium floribundum.
    Arch Virol. 2024;169:86.
    

    >> Share

    
    March 2024
31. LATIFI T, Kachooei A, Jalilvand S, Zafarian S, et al
    Correlates of immune protection against human rotaviruses: natural infection and vaccination.
    Arch Virol. 2024;169:72.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share